Drug Topics

AUGUST 4, 2024

In case you missed it, this week we had news about CVS in the spotlight of PBM reform, landmark FDA approvals in synovial sarcoma, liraglutide for dementia, and more.

FDA 186

FDA 186

Fierce Healthcare

AUGUST 4, 2024

Medical records software giant Epic has rolled out a new feature that makes it easier for patients to release their medical records to the health or wellness apps they use. | The new capability is part of a wider effort by the healthcare industry, facilitated by new health tech policies from the federal government, to advance data-sharing at scale.

Medical Records 143

Medical Records 143

STAT

AUGUST 4, 2024

With Chinese swimmers getting 200 drug tests over 10 days ahead of the Paris Olympics, all eyes are on the World Anti-Doping Agency (WADA). Anti-doping is being politicized and some important questions are being asked with this Chinese fiasco. We believe an important question is this: Do performance-enhancing drugs actually work, or are they just placebos?

128

128

Pharmacy Times

AUGUST 4, 2024

Zuranolone enhances health care providers’ ability to address the complex needs of patients with PPD, offering new hope for rapid and sustained relief from depressive symptoms.

123

123

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

BioPharm

AUGUST 4, 2024

Contract organizations offer sponsors specialized equipment, capacity, and expertise for testing, manufacturing, and packaging bio/pharmaceutical products.

Packaging 119

Packaging 119

The Guardian - Pharmaceutical Industry

AUGUST 4, 2024

Analysis suggests extent of problem UN estimates is causing 500,000 deaths a year in sub-Saharan region A fifth of medicines in Africa could be substandard or fake, according to a major research project, raising the alarm over a problem that could be contributing to the deaths of countless patients. Researchers from Bahir Dar University in Ethiopia analysed 27 studies in the review and found, of the 7,508 medicine samples included, 1,639 failed at least one quality test and were confirmed to be

110

110

The Guardian - Pharmaceutical Industry

AUGUST 4, 2024

Poll reveals emergency contraception, free prescription deliveries and extended opening hours among services hit Pharmacies across England are unable to provide critical NHS and public health services owing to the overwhelming financial and operational pressures they are facing, according to research. A poll of pharmacy owners representing more than 2,100 pharmacies found that more than 96% of respondents said they had stopped providing locally commissioned services over the past 12 months.

98

98

Drug Topics

AUGUST 4, 2024

Lifestyle changes—including eating fruits, vegetables, and whole grains—can help patients, especially those with diabetes or hypertension, improve outcomes.

98

98

pharmaphorum

AUGUST 4, 2024

An FDA advisory committee has recommended approval of Zevra Therapeutics' arimoclomol for the ultra-rare disorder Niemann-Pick disease, three years after the regulator rejected the drug.The Genetic Metabolic Diseases Advisory Committee (GeMDAC) voted 11 to five that the data support the approval of the drug for Niemann-Pick disease type C (NPC), a progressive genetic disorder that leads to the accumulation of fatty substances in tissues and can cause a range of symptoms, including liver and lung

FDA 85

FDA 85

Drug Topics

AUGUST 4, 2024

As clinical research continues, investigators are learning more about how GLP-1 drugs modify cardiovascular risks.

76

76

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.